Of Homoeopathic system
Homoeopathic medicaments in measured doses for retail sale
HSN 3004 90 14 (Of Homoeopathic system) is subject to Ministry of Environment, Forest and Climate Change (MEFCC) oversight and Directorate General of Foreign Trade (DGFT) import-policy controls under the ITC (HS) framework. The import of oxytocin is prohibited under S.O. 2357(E) and DGFT Notification 09/2015-2020 dated 23-05-2022, with a narrow exemption permitting import of oxytocin reference standards exclusively for test and analysis upon submission of a test licence issued by DCGI/CDSCO.
- Certificate of Analysis from issuing authority
- Batch release certificate from manufacturer
- Label of consignment from importer
Procedural directions for customs clearance are issued by: Directorate General of Foreign Trade.
- 1Verify that the specific homoeopathic medicament being imported is not oxytocin or an oxytocin-containing formulation — import of oxytocin is prohibited. If the consignment comprises oxytocin reference standards for test and analysis only, obtain a test licence from DCGI/CDSCO and submit it at the bill of entry.S.O. 2357(E) dated 23-05-2022 · DGFT Notification 09/2015-2020 dated 23-05-2022
- 2Upload the mandatory e-Sanchit documents before filing the bill of entry: Certificate of Analysis — Drug (document code 0010dc), Batch Release Certificate (document code 0030dc), and Label of Consignment (document code 0110dc). Customs out-of-charge will not be granted until all three documents are verified in e-Sanchit.CBIC e-Sanchit mandatory document verification requirement · document codes 0010dc, 0030dc, 0110dc
- 3If the consignment includes used or refurbished medical equipment falling within the high-end, high-value category (other than critical care equipment), confirm compliance with the conditions specified in the Ministry of Environment, Forest and Climate Change Office Memorandum dated 15-12-2023, as import of such equipment is Restricted.O.M. issued by Ministry of Environment, Forest and Climate Change dated 15-12-2023
The most common error on this tariff line is conflating the general prohibition on oxytocin imports with the narrow test-and-analysis exemption: importing oxytocin reference standards without a current DCGI/CDSCO test licence — even in small quantities — constitutes a prohibited-import violation, attracting confiscation and monetary penalty. The exemption is purpose-specific and quantity is not a substitute for documentary compliance; a consignment detained for a missing test licence is not eligible for regularisation on payment of enhanced duty.